Few of the many nonpharmacologic efforts to mitigate the spread of COVID-19 in nursing homes during the pandemic were ...

New research showed some long COVID patients get symptom relief by taking an extended course of Paxlovid. Data are ...

US-based Inhalon Biopharma is set to launch a trial of its at-home nebulised treatment for respiratory syncytial virus (RSV) ...

The antibody targets a stable part of the bird flu virus, ensuring that the immune protection can resist new variants and offer long-term protection against the globally spreading airborne infection.

The stock is trading at 1.0150, up 0.6573, gaining 183.7573% on volume of over 422 Million shares, with a day's high of $1.11. The stock announced breaking news on its Monoclonal Antibody designed to ...

In the midst of pandemic upheaval, researchers have gained fundamental insights about how the body fends off infections.

It’s been estimated that about 400 million people worldwide have had long COVID. Some researchers say that number is much ...

Antibody Therapy MarketThe global antibody therapy market is on a strong growth trajectory, projected to expand at a CAGR of ...

A new antibody therapy effectively protects monkeys from severe H5N1 avian flu, offering hope for a universal flu vaccine and ...

Five years after SARS-CoV-2 first surfaced in Wuhan, China, researchers are still trying to understand long COVID. In this ...